Psychotropic medications in autism: practical considerations for parents.
A plain-language pill guide for parents that slots neatly beside your behavior plan.
01Research in Context
What this study did
Lerner et al. (2012) wrote a parent-friendly guide. It explains pills for kids with autism.
The guide covers irritability, hyper-focus, and repeated actions. It is not a new experiment.
What they found
The paper lists common pills and what parents should watch for.
It gives tips like “ask about side effects” and “start with low doses.”
How this fits with other research
Stancliffe et al. (2007) tested one of those pills, risperidone, in a real trial. Kids on the pill calmed down more than kids on placebo.
Heavey et al. (2000) tried methylphenidate for hyper-focus. Eight of thirteen kids moved less, but some got grouchy.
Hirota et al. (2014) later pooled seven trials of seizure medicines. They found no clear help for irritability. This warns parents that not every pill works.
Trembath et al. (2023) looked at all non-drug treatments. They say no single therapy fits every child. This pushes parents to weigh pills against behavior plans, not instead of them.
Why it matters
You can hand this guide to families at intake. It opens talk about medicine without pushing it. Pair it with behavior plans and keep tracking data. If a doctor adds a pill, you still run your program and watch for change.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Print the guide and add it to your intake packet.
02At a glance
03Original abstract
Medications are widely prescribed in children with autism spectrum disorders. Most commonly these medications are used to decrease symptoms that fall under three main clusters: irritability, ADHD-like symptoms, and repetitive behaviors. In this guide we introduce basic approaches to medications in children with autism and review the scientific evidence in each symptom cluster.
Journal of autism and developmental disorders, 2012 · doi:10.1007/s10803-010-1144-2